RetaPath
Evidence-based protocol tracking
Track your Retatrutide protocol against published Phase 2 trial data. Built for weight loss, bodybuilding, and longevity goals.
Weight LossBodybuildingLongevity
338
Trial Participants
17%
Max Weight Loss
24wk
Study Duration
Latest — March 2026
Eli Lilly's retatrutide clears Phase 3 diabetes trial
FDA approval is getting closer. Join 150+ users already tracking their Retatrutide protocol on RetaPath.
Read on CNBC →Free plan — no credit card required
- ✓Weekly check-in logging
- ✓Weight & dose tracking
- ✓Progress dashboard & charts
- ✓Dose escalation alerts
- ✓Full check-in history
- ✓Biomarker tracking (glucose, HbA1c, CRP, triglycerides)
- ✓Protocol calculator (lbs & kg)
- ✓Weight loss, bodybuilding & longevity protocols
- ✓Weekly dose reminder emails
- ✓WhatsApp community access
Already have an account? Log in
For informational purposes only. Not medical advice. Based on published clinical trial data.
Questions or feedback? support@retapath.com